5th Modern Drug Discovery & Development Summit (M3D2009)
Venue: San Diego
|Event Date/Time: Oct 14, 2009||End Date/Time: Oct 16, 2009|
|Abstract Submission Date: Sep 14, 2009|
The number of biologics approvals has continued to increase over the last decade and big pharma companies canâ€™t afford to â€œmiss outâ€. Since biologics are by definition drawn out of a growing understanding of biology, their activity is inherently more predictable and their development times shorter. In addition, biologics appear less susceptible to generic competition, although as new â€œbiosimilarsâ€ regulations are enacted and take effect, this advantage may diminish somewhat. And as early biologics themselves approach patent expiration, new drug delivery technologies for peptide and protein drugs have assumed central importance in life-cycle management and product proliferation strategies.
The conference provides its participants with a current look at biologics and projects into its future with discussions regarding developments and challenges in immunogenicity, humanization, drug delivery techniques for biologics, modern vaccine development, antibodies, and novel protein and peptide delivery. Overcoming the issue of the role of biologics in drug discovery and how to improve upon the length of time a drug remains effective in the body, without losing money, will be addressed.